期刊文献+

门静脉癌栓微波消融及射频消融治疗80例分析 被引量:10

Percutaneous microwave ablation and radiofrequency ablation for the treatment of portal vein tumor thrombus: clinical analysis of 80 cases
在线阅读 下载PDF
导出
摘要 目的报道两种针对肝癌门静脉癌栓的治疗技术,并比较其疗效。方法本研究共纳入162例肝癌合并门脉癌栓的患者。治疗组中80例患者在经肝动脉插管化疗栓塞术(TACE)基础上接受了直接微波消融术、射频消融等治疗方案,对照组82例患者仅接受TACE术。结合文献报道及医疗实践,我们探讨了合理的标准手术流程并分析了临床结果。结果未观察到严重并发症。术后3个月时复查肝脏增强MRI显示5例(6.2%)患者静脉癌栓完全消失,14例(17.5%)患者静脉癌栓明显缩小,43例(53.8%)静脉癌栓稳定,18例(22.5%)静脉癌栓进展。治疗组门静脉癌栓进展显著慢于对照组(P<0.001)。结论直接微波消融术用于肝内段门静脉癌栓,经皮肝穿刺门静脉消融导管术用于肝外段门静脉癌栓上较为安全有效。 Objective To introduce two treatment techniques for portal vein tumor thrombus of hepatocellular carcinoma (HCC) , and to compare their curative effects. Methods A total of 162 HCC patients with portal vein tumor thrombus were included in this study. After having transcatheter arterial chemoembolization ( TACE ), patients of the study group ( n = 80 ) received additional direct percutaneous microwave ablation (PMWA), radiofrequency catheter ablation, and other therapies; while patients of the control group (n= 82) received TACE only. Combined with literature reports and medical practice, the reasonable standard operation procedure was discussed and the clinical results were analyzed. Results No severe complications were observed. Contrast-enhanced MRI performed at 3 months after the treatment showed that complete disappearance of portal vein tumor thrombus was achieved in 5 patients ( 6.2% ) and obvious shrinkage of portal vein tumor thrombus in 14 patients ( 17.5%), stable portal vein tumor thrombus was seen in 43 patients (53.8%) and progression of portal vein tumor thrombus in 18 patients (22.5%).The progression of portal vein tumor thrombus in the study group was significantly slower than that in the control group ( P〈0.001 ). Conclusion It is safer and more effective to use direct percutaneous microwave ablation for portal vein tumor thrombus within intrabepatic segment and to use pereutaneous liver puncture portal catheter radiofrequency ablation for portal vein tumor thrombus within extrahepatic segment.
出处 《介入放射学杂志》 CSCD 北大核心 2016年第6期510-514,共5页 Journal of Interventional Radiology
基金 国家自然科学基金(81301302) 上海市科委医学引导类科技项目(15411966100) 上海市市级医院新兴前沿技术联合攻关项目(SHDC12014112)
关键词 射频消融 肝癌 门静脉癌栓 radiofrequency ablation hepatocellular carcinoma portal vein tumor thrombus
  • 相关文献

参考文献10

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61: 69-90.
  • 2程树群,李楠,吴孟超.门静脉癌栓分型与治疗选择[J].中国普外基础与临床杂志,2012,19(3):240-242. 被引量:37
  • 3Chau GY, Ixti WY, Wu CW. Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma[ J]. Surg Oncol Clin N Am 2003, 12: 25-34.
  • 4Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma[J]. CA Cancer J Clin, 2012, 62.. 394-399.
  • 5FornerA, Llovet JM, Bruix J. Hepatoeellular earcinoma[J]. Lancet, 2012, 379: 1245-1255.
  • 6Llovet JM, Ducreux M, Lencioni R, et al. EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma [ J ]. J Hepatol, 2012, 56: 908-943.
  • 7中国抗癌协会肝癌专业委员会.中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].中华医学信息导报,2009,24:22-23.
  • 8Thanos L, Sotiropoulou E, Tanteles S, et al. Direct radiofrequency ablation of portal vein tumor thrombus in continuity with hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2010, 21: 285-288.
  • 9Giorgio A, Di Sarno A, De Stefano G, et al. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus? [ J]. AJR Am J Roentgenol, 2009, 193: 948-954.
  • 10葛乃建,杨业发,申淑群,于晓河,张一军,伍路,梁军,朱俊军,程树群,沈锋,吴孟超.经皮穿刺射频消融治疗门静脉癌栓15例[J].介入放射学杂志,2014,23(10):883-886. 被引量:15

二级参考文献16

  • 1石洁,程树群.放射治疗肝癌门静脉癌栓的现状及展望[J].中国微创外科杂志,2005,5(2):125-126. 被引量:5
  • 2梅铭惠,陈谦,杨景红,徐静,邱维加,曾思恩,唐建华.肝癌合并门静脉癌栓的临床病理分级及意义[J].中华肝胆外科杂志,2006,12(6):374-377. 被引量:16
  • 3Chau GY,Lui WY,Wu CW.Spectrum and significance of mi-croscopic vascular invasion in hepatocellular carcinoma[J].SurgOncol Clin N Am,2003,12(1):25-34,viii.
  • 4Shi J,Lai EC,Li N,et al.A new classification for hepatocellularcarcinoma with portal vein tumor thrombus[J].J HepatobiliaryPancreat Sci,2011,18(1):74-80.
  • 5Feng YX,Wang T,Deng YZ,et al.Sorafenib suppresses post-surgical recurrence and metastasis of HCC in an orthotopic mousemode[J].Hepatology,2011,53(2):483-492.
  • 6Shi J,Lai E,Li N,et al.Surgical treatment of hepatocellular car-cinoma with portal vein tumor thrombus[J].Ann Surg Oncol,2010,17(8):2073-2080.
  • 7Lee HS,Kim JS,Choi IJ,et al.The safety and efficacy of trans-catheter arterial chemoembolization in the treatment of patientswith hepatocellular carcinoma and main portal vein obstruction.Aprospective controlled study[J].Cancer,1997,79(11):2087-2094.
  • 8Zeng ZC,Fan J,Tang ZY,et al.Acomparison of treatment com-binations with and without radiotherapy for hepatocellular carcino-ma with portal vein and/or inferior vena cava tumor thrombus[J].Int J Radiat Oncol Biol Phys,2005,61(2):432-443.
  • 9Lazoura O, Zacharoulis D, Kanavou T, et al. A novel experimental animal model of arterial stenosis based on endovascular radiofrequency energy application [J]. J Invest Surg, 2011, 24:123 - 128.
  • 10Shi J, Lai EC, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus [J]. J Hepatobiliary Pancreat Sci, 2011, 48:74 - 80.

共引文献49

同被引文献122

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部